13 July 2023 in Angewandte Chemie International Edition
9 February 2021 in Journal of Proteome Research
Comprehensive cancer data sets recently generated by the Clinical Proteomic Tumor Analysis Consortium (CPTAC) offer great potential for advancing our understanding of how to combat cancer. These data sets include DNA, RNA, protein, and clinical characterization for tumor and normal samples from large cohorts of many different cancer types. The raw data are publicly available at various Cancer Research Data Commons. However, widespread reuse of these data sets is also facilitated by easy access to the processed quantitative data tables. We have created a data application programming interface (API) to distribute these processed tables, implemented as a Python package called cptac. We implement it such that users who prefer to work in R can easily use our package for data access and then transfer the data into R for analysis. Our package distributes the finalized processed CPTAC data sets in a consistent, up-to-date format. This consistency makes it easy to integrate the data with common graphing, statistical, and machine-learning packages for advanced analysis. Additionally, consistent formatting across all cancer types promotes the investigation of pan-cancer trends. The data API structure of directly streaming data within a programming environment enhances the reproducibility. Finally, with the accompanying tutorials, this package provides a novel resource for cancer research education. View the software documentation at https://paynelab.github.io/cptac/. View the GitHub repository at https://github.com/PayneLab/cptac.
13 July 2023 in Angewandte Chemie
5 March 2023 in Biotechnology Progress
17 July 2025 in Journal of Proteome Research
JCJose Humberto Giraldez Chavez
Jose Humberto Giraldez Chavez
As a diverse family of diseases, cancer is unified by a set of common dysfunctions, such as limitless growth potential and an insensitivity to antigrowth signals. These shared overarching biological processes have been termed the hallmarks of cancer. To better understand the root cause of cellular dysregulation, intense molecular characterization of tumors has utilized DNA, RNA, and protein measurement techniques to produce proteogenomic data. In large cancer cohort studies, genomic and proteogenomic data have frequently identified many cancer hallmarks including cell cycle and cell signaling. However, altered metabolism, a known cancer hallmark, is not as clearly identified in mutation screens or differential expression analyses. Here, we introduce a new computational method to identify changes in cellular regulation by focusing on the mRNA/protein relationship. We create a metric, Δ_corr, to capture when the mRNA/protein correlation changes significantly between tumor and normal tissues and show that it is distinct from differential expression and also not associated with DNA mutation profiles. Our method clearly highlights altered metabolic pathways across multiple tumor types. Δ_corr gives researchers a new perspective on the dysfunction of tumor cells and introduces a novel method for proteogenomic data integration.